Advertisement

Topics

Patent delisted for Eli Lilly drug ADCIRCA

20:09 EDT 16 Apr 2019 | BiotechBlog

Annual Drug Patent Expirations for ADCIRCA Adcirca is a drug marketed by Eli Lilly Co and is included in one NDA. It is available from two suppliers. There are two…
The post Patent delisted for Eli Lilly drug ADCIRCA appeared first on DrugPatentWatch -...

The post Patent delisted for Eli Lilly drug ADCIRCA appeared first on Biotechblog.

Original Article: Patent delisted for Eli Lilly drug ADCIRCA

NEXT ARTICLE

More From BioPortfolio on "Patent delisted for Eli Lilly drug ADCIRCA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...